The People Making it Happen
Our team has years of experience successfully developing and commercializing medical devices.
“We are positively transforming people’s lives.”
– Dr. Chris Springate, ARC CEO
Dr. Chris Springate
Chief Executive Officer
Dr. Chris Springate has over 25 years of experience as a leader in the development of medical devices, combination products and drugs at preclinical and early clinical stage medical device companies. He engaged in the development of several successful products including the Taxus® Stent with sales of greater than USD 1 billion annually; built leadership teams including corporate, scientific and clinical boards; co-led ARC in acquiring greater than USD 30 million of equity and licensing financing; and is an inventor of several patent families that protect ARC’s products. Dr. Springate served as a hospital and community pharmacist for 7 years. He holds BSc (Pharm) and PhD (Pharm) degrees and is a Registered Pharmacist.
Chief Financial Officer
30+ years experience building healthcare companies with successful exits, including ImmGenics, which was acquired for $120 million cash, and QLT which had a market cap of more than $250 million. (part-time)
Dr. Hesong Sun
VP of Product Development and Operations
10+ years experience in the fields of preclinical research, cell biology, immunology and 1+ years clinical experience, including managing a top research laboratory at the University of Toronto.
Marketing and Quality Director
30+ years experience leading quality teams, product design and project management. Led the building and certification of Advanced Cyclotron Systems’ ISO 13485 quality management system and was instrumental in Ossur orthopedics’ medical device product design.
Regulatory, Risk and Clinical
Aileen has over 5 years of hands-on experience in regulatory compliance, clinical design, risk management, and manufacturing process design, research and development. She is also the inventor of several patent families that protect ARC’s products. Aileen has previously held research and development positions in the Environmental Energy Division of Lawrence Berkeley National Laboratory as well as University of California Berkeley. She is an active member of Engineers and Geoscientists BC (EGBC) and had previously served on the Student Liaison Committee at Association of Professional Engineers and Geoscientists of Alberta (APEGA) that connects university students with industry professionals to promote networking and communication. Aileen has received Queen Elizabeth II Graduate Scholarships in recognition of outstanding academic achievement during her graduate studies and University of California Berkeley College of Chemistry Dean’s Honors List in recognition of outstanding academic achievement during her undergraduate studies. Aileen holds a Bachelor of Science (BSc) degree in Chemical Engineering and Master of Engineering degree (MEng) in Chemical Engineering.
Clinical Trials Coordinator
25+ years experience in surgical adhesion product clinical trials and commercialization including Seprafilm®, Sepracoat®, Adept®, AdSpray® and Actamax Adhesion Barrier. (part-time)
Intellectual Property, Business Development and Legal
Sailesh leads the drafting, filing and prosecuting of ARC’s broad patent portfolio, resulting in ARC obtaining several issued patents and recently filing numerous key patents that protect ARC’s products and processes through 2039. Sailesh is knowledgeable regarding nuances in patenting healthcare related inventions including the application of the Hatch-Waxman act, regulatory data protection in Europe and Canada, and patentable subject matter in key jurisdictions. Sailesh also oversees ARC’s trademark portfolio and marking of ARC’s copyright materials.
Sailesh leads ARC’s business development activities, including assisting with ARC’s first out-license deal in Japan, managing ARC’s in-licensed technology, and procuring key deals with suppliers and consultants.
Sailesh possesses over 7 years of experience in polysaccharide research and has co-developed projects with the ARC team on fucoidan extraction, purification, structural modification, and characterization, resulting in substantial contribution of matter to ARC’s recently filed key patents. Sailesh was also engaged in the transfer of ARC’s bench-scale production experiments to pilot scale production processes, resulting in ARC manufacturing its adhesion barrier product at an appreciable scale.
Sailesh holds a BSc (Honors) in Chemistry (his thesis was on polysaccharides) with a minor in commerce, a diploma in data science, a certificate in web development and certificates in patenting.
Steve has more than 25 years experience as an IT director and IT leader, consultant, and application developer for life sciences companies. He oversaw all aspects of IT through numerous mergers, acquisitions, moves, regulatory compliance initiatives, enterprise software implementations, cloud migrations, etc. Steve held positions and provided services for companies of varying stages, regulatory agencies, and NGOs, including Angiotech, Novopharm, BASF, Health Canada, Industry Canada, Agriculture Canada, UBC Fisheries, Telefonica, Sun Microsystems, BC Biotechnology Alliance, and Centre for Digital Media.
Steve holds a Master of Digital Media degree awarded by UBC, SFU, ECIAD, BCIT and a BSc from UWaterloo.
Steve’s other passions are game development, hobby farming, kitesurfing, and angel investing.
Dr. Geoffrey Trew
Gynecology Surgeon and Adhesion Prevention Key Opinion Leader
He qualified at St Georges Medical School, University of London in 1984. He started his training in Reproductive medicine and surgery at Guys Hospital London in 1989 and was appointed lecturer at the Royal London Hospital in 1992. He moved to the Hammersmith Hospital in 1993 to continue under Prof Lord Robert Winston until 1995 when he was appointed Consultant in Reproductive Medicine & Surgery as well as Honorary Senior Lecturer in Imperial College London.
He was the RCOG Training Programme Director for NW London for 12 years and Chief of Service for Reproductive Medicine for Imperial College NHS Trust for 10 years.
In 2012 he was one of the Founding Directors of what is now ‘The Fertility Partnership’ and continues as the Group Clinical Director. He is still an Honorary Senior Lecturer at Imperial College London, but retired from the NHS 2 years ago.
He has published over 120 peer reviewed journals as well as over 15 chapters for text books. He lectures both nationally and internationally in the field of reproductive medicine and surgically he is internationally known for his work in peritoneal and uterine adhesions. He is one of the few surgeons recommended by the International Ashermans Society.
Dr. Donald Menzies
Abdominal Surgeon and Adhesion Prevention Key Opinion Leader
Dr. Donald Menzies is a general surgeon with more than 35 years of experience and a particular interest in adhesions, gastro-oesophageal reflux, gall stones, incisional and groin hernias, and therapeutic endoscopy at Colchester General Hospital and Ramsay Oaks Hospital, Essex. He obtained his Master of Surgery in abdominal adhesions at the University of London and is an expert in minimal access surgery using laparoscopic techniques, having performed such procedures since 1992. During his clinical appointment at Westminster hospital he completed a series of experimental studies in collaboration with Genentech (USA) that investigated adhesion formation. These studies have been coupled with a clinical analysis of the incidence of adhesions in over 28,000 surgical admissions, an examination of the incidence and site of adhesion production after abdominal surgery and an examination of the type of post-operative adhesion that produce intestinal obstruction. For this research he was awarded the Hunterian Professorship, Royal College of Surgeons of England and Wales (1990 – 1991). He has been closely involved in other adhesion related research involving the SCAR studies which identified the national burden of adhesion disease, and the ARIEL registry, an international record of the use of an anti-adhesion barrier.
Dr. Menzies is the President of the Association of Laparoscopic Surgeons of Great Britain and Ireland, a member of the British Medical Association, the Association of Upper GI Surgeons and the Association of Surgeons. He is a Fellow of the Royal College of Surgeons of England.
He is currently the Senior Consultant General Surgeon at Colchester Hospital University Foundation Trust and Ramsay Oaks Hospital, Colchester.
Prof. Michael Diamond
Gynecology Surgeon and Adhesion Prevention Key Opinion Leader
Internationally renowned clinical investigator and principal investigator or Co-PI on over 45 commercial clinical trials including postoperative adhesions; a long track record of conduct of prospective clinical studies and randomized controlled clinical trials; played leading roles in design and conduct of the preclinical/clinical studies leading to FDA approval of the first two agents for reduction of postoperative intra-abdominal adhesions approved and available in the United States (Interceed and Seprafilm). Served on multiple study sections and special review committees for the National Institutes of Health (NIH). Past president of the Society for Reproductive Endocrinology and Infertility, and the Society of Reproductive Surgeons; served on the board of directors for many other national and international societies including the American Society for Reproductive Medicine, the Society for Gynecologic Surgeons, and the AAGL Advancing Minimally Invasive Gynecology Worldwide. Contributed to over 575 peer reviewed manuscripts, 135 chapters, and 880 abstracts; edited or co-edited over 20 books and journal issues. He has given over 820 scientific presentations, and has been extensively involved in health care provider education, including participating in the training of medical students and OB/GYN residents; also served as Reproductive Endocrinology and Infertility Fellowship Director, in total training over thirty REI fellows.
Dr. Alex McConnachie
Clinical Trial Biostatistics Leader
Alex McConnachie is a Professor of Clinical Trial Biostatistics, and Assistant Director of Biostatistics at the Robertson Centre for Biostatistics, University of Glasgow. He has played a significant role in the design and/or analysis of many medical research projects, including over 65 randomised trials, two of which were clinical trials regarding surgical adhesions. Prof McConnachie has more than 250 publications and his research has been cited more than 13,000 times.
Manufacture and Supply
Dr. Mohammad Azim
Dr. Maurice Ndagijimana